Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer

Clinical trial NCT02488967 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02488967
Sponsor: NRG Oncology
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Breast Adenocarcinoma Estrogen Receptor Negative HER2/Neu Negative Progesterone Receptor Negative Stage IB Breast Cancer Stage IIA Breast Cancer Stage IIB Breast Cancer Stage IIIA Breast Cancer Stage IIIC Breast Cancer Triple-Negative Breast Carcinoma

Start date: 2015-07-26
Primary completion: 2025-12-31
Enrollment: 782

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.